134 related articles for article (PubMed ID: 1292525)
1. Thromboxane B2 urinary metabolites in patients undergoing cardiopulmonary bypass.
Jörres A; Chiabrando C; Kordonouri O; Schiessler A; Hess S; Farke S; Gahl GM; Müller C; Rivoltella L; Djurup R
Eicosanoids; 1992; 5(3-4):147-51. PubMed ID: 1292525
[TBL] [Abstract][Full Text] [Related]
2. [Changes in urinary immunoreactive-TXB2 and 2,3-dinor TXB2 in man following cardiopulmonary bypass].
Arima T; Ueda K; Genda T; Omoto R; Matsumoto I; Hori T
Masui; 1989 Apr; 38(4):512-6. PubMed ID: 2724515
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass.
Jörres A; Kordonouri O; Schiessler A; Hess S; Farke S; Gahl GM; Müller C; Djurup R
Artif Organs; 1994 Aug; 18(8):565-9. PubMed ID: 7527629
[TBL] [Abstract][Full Text] [Related]
4. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
6. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G
Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
[TBL] [Abstract][Full Text] [Related]
7. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
8. [Changes in urinary prostaglandins during cardiopulmonary bypass in man].
Arima T; Ohata M; Matsuura M; Nakamura S; Matsumoto I; Hori T
Masui; 1989 Jul; 38(7):908-12. PubMed ID: 2614902
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
10. Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry.
Djurup R; Chiabrando C; Jörres A; Fanelli R; Foegh M; Soerensen HU; Joergensen PN
Clin Chem; 1993 Dec; 39(12):2470-7. PubMed ID: 8252718
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.
Chiabrando C; Rivoltella L; Alberti E; Bonollo M; Djurup R; Fanelli R
Prostaglandins; 1993 May; 45(5):401-11. PubMed ID: 8321910
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat.
Chiabrando C; Corada M; Bachi A; Fanelli R
Prostaglandins; 1994 Jun; 47(6):409-22. PubMed ID: 7938613
[TBL] [Abstract][Full Text] [Related]
14. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
15. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
Ylikorkala O; Saarela E; Viinikka L
J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
[TBL] [Abstract][Full Text] [Related]
16. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
[TBL] [Abstract][Full Text] [Related]
17. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia.
Milani M; Cimminiello C; Lorena M; Arpaia G; Soncini M; Bonfardeci G
Biomed Pharmacother; 1996; 50(6-7):269-74. PubMed ID: 8952866
[TBL] [Abstract][Full Text] [Related]
18. The importance of urinary thromboxane B2 excretion in the diagnosis of acute renal rejection.
Ortuño J; González-Revalderia J; Teruel JL; Villafruella JJ; Sabater J; Matesanz R; Quereda C
Nephrol Dial Transplant; 1988; 3(3):305-11. PubMed ID: 3140106
[TBL] [Abstract][Full Text] [Related]
19. Increased renal biosynthesis of prostaglandin E2 and thromboxane B2 in human congenital obstructive uropathy.
Kühl PG; Schönig G; Schweer H; Seyberth HW
Pediatr Res; 1990 Jan; 27(1):103-7. PubMed ID: 2296464
[TBL] [Abstract][Full Text] [Related]
20. Urinary proteomics before and after extracorporeal circulation in patients with and without acute kidney injury.
Aregger F; Pilop C; Uehlinger DE; Brunisholz R; Carrel TP; Frey FJ; Frey BM
J Thorac Cardiovasc Surg; 2010 Mar; 139(3):692-700. PubMed ID: 20176211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
